Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Epistaxis
ADR ID BADD_A01528
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.03      Nasal disorders NEC
22.04.03.001      Epistaxis
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.01      Haemorrhages NEC
24.07.01.005      Epistaxis
Description A disorder characterized by bleeding from the nose. [CTCAE] Bleeding from the nose. [MeSH]
MedDRA Code 10015090
MeSH ID D004844
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bleeding nose | Epistaxis | Haemorrhage nasal | Hemorrhage nasal | Nasal bleeding | Nasal mucus blood tinged | Nose bleed | Nose bleeds | Nosebleed | Chronic epistaxis | Blood clot in nose | Nasal Bleeding | Bleeding, Nasal | Bleedings, Nasal | Nasal Bleedings | Nose Bleed | Nose Bleeds | Nosebleeds
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01605Olopatadine--
BADD_D01606Olopatadine hydrochloride--
BADD_D01609Omacetaxine mepesuccinate0.000112%
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01614Omeprazole--
BADD_D01615Omeprazole magnesium--
BADD_D01621Optimark--
BADD_D01627Oseltamivir--
BADD_D01628Oseltamivir phosphate--
BADD_D01633Oxaliplatin--
BADD_D01637Oxcarbazepine--
BADD_D01643Oxybutynin--
BADD_D01645Oxycodone--
BADD_D01646Oxycodone hydrochloride--
BADD_D01653Paclitaxel--
BADD_D01654Palbociclib0.045969%
BADD_D01656Paliperidone--
BADD_D01659Palonosetron--
BADD_D01668Pantoprazole0.000114%
BADD_D01676Paricalcitol--
BADD_D01679Paroxetine--
BADD_D01680Paroxetine hydrochloride--
BADD_D01681Paroxetine hydrochloride hemihydrate--
BADD_D01682Paroxetine impurity a--
BADD_D01683Paroxetine mesylate--
BADD_D01687Pazopanib0.004835%
BADD_D01688Pazopanib hydrochloride--
BADD_D01701Pemetrexed0.000224%
BADD_D01728Pentosan polysulfate--
BADD_D01729Pentosan polysulfate sodium--
The 13th Page    First    Pre   13 14 15 16 17    Next   Last    Total 20 Pages